Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Male PRLomas, compared to females, tend to be larger and more invasive, are associated with higher PRL concentration at diagnosis, present higher proliferative potential, are more frequently resistant to standard pharmacotherapy, and thus may require multimodal approach, including surgical resection, radiotherapy, and alternative medical agents
2025 Aug:74:589-607
Kumar, S., & Tiwari, S
As of the time of writing, retatrutide has not been granted a marketing authorisation by the MHRA in the United Kingdom, nor has it received approval from the European Medicines Agency (EMA)
US$ 29.44
US$ 28.12
US$ 26.64
US$ 21.48
US$ 27.76
